Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1618090-10-0

Post Buying Request

1618090-10-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1618090-10-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1618090-10-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,1,8,0,9 and 0 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1618090-10:
(9*1)+(8*6)+(7*1)+(6*8)+(5*0)+(4*9)+(3*0)+(2*1)+(1*0)=150
150 % 10 = 0
So 1618090-10-0 is a valid CAS Registry Number.

1618090-10-0Downstream Products

1618090-10-0Relevant articles and documents

New insights into the biological properties of Crocus sativus L.: Chemical modifications, human monoamine oxidases inhibition and molecular modeling studies

De Monte, Celeste,Carradori, Simone,Chimenti, Paola,Secci, Daniela,Mannina, Luisa,Alcaro, Francesca,Petzer, Anél,N'Da, Clarina I.,Gidaro, Maria Concetta,Costa, Giosuè,Alcaro, Stefano,Petzer, Jacobus P.

, p. 164 - 171 (2014/06/24)

Although there are clinical trials and in vivo studies in literature regarding the anxiolytic and antidepressant activities of the components of Crocus sativus L., their effects on the human monoamine oxidases (hMAO-A and hMAO-B), enzymes which are involved in mental disorders and neurodegenerative diseases, have not yet been investigated. We have thus examined the hMAO inhibitory activities of crocin and safranal (the most important active principles in saffron) and, subsequently, designed a series of safranal derivatives to evaluate which chemical modifications confer enhanced inhibition of the hMAO isoforms. Docking simulations were performed in order to identify key molecular recognitions of these inhibitors with both isoforms of hMAO. In this regard, different mechanisms of action were revealed. This study concludes that safranal and crocin represent useful leads for the discovery of novel hMAO inhibitors for the clinical management of psychiatric and neurodegenerative disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1618090-10-0